Histone cluster 3 H2BB Inhibitors
Histone cluster 3 H2BB inhibitors constitute a specialized chemical class designed to selectively target and modulate the function of H2BB histone proteins. H2BB, as a variant within the histone cluster 3 family, plays an integral role in the dynamic regulation of chromatin structure and gene expression. Serving as a crucial component of nucleosomes, H2BB contributes to the compaction of DNA, exerting influence over the intricacies of gene regulation within the cellular context. The inhibitors tailored for Histone cluster 3 H2BB are intricately designed to interact with the specific molecular structure of this histone variant, with the aim of disrupting its normal interactions within the nucleosome and potentially influencing the broader chromatin landscape.
The molecular architecture of Histone cluster 3 H2BB inhibitors is carefully crafted to engage specific binding sites on H2BB, inducing changes in its conformation and dynamics. This interaction holds the potential to impact the accessibility of DNA, thereby influencing the regulatory processes governing gene expression. In laboratory investigations, these inhibitors serve as valuable tools, enabling researchers to delve into the nuanced roles of H2BB in diverse cellular processes and contributing to a deeper understanding of chromatin biology. By manipulating the function of H2BB, scientists aim to unravel the intricate mechanisms of gene regulation, shedding light on the broader implications of epigenetic processes for cellular function and development. The exploration of Histone cluster 3 H2BB inhibitors stands at the forefront of advancing our understanding of chromatin dynamics and the finely tuned orchestration of gene expression within the cellular milieu.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), leading to increased histone acetylation. This alteration may suppress the expression of H2B clustered histone 26. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a bromodomain inhibitor, disrupting the binding of bromodomain-containing proteins to acetylated histones. This interference may impact the transcription of H2B clustered histone 26. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor, preventing the degradation of proteins. Inhibition of proteasomal activity may affect the turnover of H2B clustered histone 26, influencing its expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor, modulating DNA methylation patterns. Altered DNA methylation may regulate the transcription of H2B clustered histone 26. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA inhibits histone deacetylases, promoting histone hyperacetylation. This epigenetic modification could potentially hinder the expression of H2B clustered histone 26. | ||||||
9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine | 1380288-87-8 | sc-500607 | 50 mg | $13500.00 | ||
EPZ-5676 is a DOT1L inhibitor, targeting histone H3 lysine 79 methylation. Disruption of this methylation pattern may impact the transcriptional regulation of H2B clustered histone 26. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a p300/CBP histone acetyltransferase inhibitor, affecting histone acetylation. Modulation of acetylation levels may play a role in inhibiting the expression of H2B clustered histone 26. | ||||||
GSK J1 | 1373422-53-7 | sc-391113 sc-391113A | 10 mg 50 mg | $193.00 $813.00 | ||
GSK-J4 is a histone demethylase inhibitor, impacting histone methylation patterns. Altered methylation may influence the transcriptional regulation of H2B clustered histone 26. | ||||||
Apicidin | 183506-66-3 | sc-202061 sc-202061A | 1 mg 5 mg | $110.00 $343.00 | 9 | |
Apicidin is a histone deacetylase inhibitor, promoting histone hyperacetylation. This epigenetic modification could potentially interfere with the expression of H2B clustered histone 26. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 is a histone methyltransferase inhibitor targeting G9a and GLP. Inhibition of these enzymes may impact histone methylation patterns, potentially influencing H2B clustered histone 26 expression. | ||||||